Definium Therapeutics, Inc. Unrealized Gain (Loss) on Investments
Definium Therapeutics, Inc. (DFTX) reported Unrealized Gain (Loss) on Investments of -$406.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-08-06
- Definium Therapeutics, Inc. unrealized gain (loss) on investments for the quarter ending 2026-06-30 was -$406.00K, a 1227.78% decline year-over-year.
- Definium Therapeutics, Inc. unrealized gain (loss) on investments for the quarter ending 2026-03-31 was -$262.00K, a 2720.00% decline year-over-year.
- Definium Therapeutics, Inc. unrealized gain (loss) on investments for the quarter ending 2025-12-31 was $88.00K.
- Definium Therapeutics, Inc. unrealized gain (loss) on investments for the quarter ending 2025-09-30 was $196.00K.
- Definium Therapeutics, Inc. unrealized gain (loss) on investments for fiscal 2025 was $330.00K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$406.00K 10-Q · filed 2026-08-06 | -$668.00K 10-Q · filed 2026-08-06 | -$580.00K derived: sum of 3 quarters · filed 2026-08-06 | -$384.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$262.00K 10-Q · filed 2026-05-07 | -$174.00K derived: sum of 2 quarters · filed 2026-05-07 | $22.00K derived: sum of 3 quarters · filed 2026-05-07 | $58.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $284.00K derived: sum of 2 quarters · filed 2026-02-26 | $320.00K derived: sum of 3 quarters · filed 2026-08-06 | $330.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $196.00K 10-Q · filed 2025-11-06 | $232.00K derived: sum of 2 quarters · filed 2026-08-06 | $242.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $36.00K 10-Q · filed 2026-08-06 | $46.00K 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | $10.00K 10-Q · filed 2026-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |